Latest news about Deccan Health Care
Deccan Health Care
13.54
+0.16(+1.20%)
Company Performance:
View Company Insights1D+1.20%
1M+8.84%
6M-12.36%
1Y-30.78%
5Y-55.75%
More news about Deccan Health Care
10Mar 26
Deccan Health Care Limited Announces Resignation of Two Independent Directors
Deccan Health Care Limited announced the resignation of two Non-Executive Independent Directors - Ms. Samhitha Kandlakunta (effective 9th March 2026) and Ms. Karishma Patel (effective 10th March 2026). Both cited personal reasons for their departure, with Kandlakunta relocating overseas for career progression and Patel facing increased workload commitments. The company has complied with all SEBI regulatory requirements and confirmed both directors have no material concerns with governance practices.
13Feb 26
Deccan Health Care Reports Strong Q3FY26 Performance with 13% Revenue Growth and 511% PAT Surge
Deccan Health Care Limited reported exceptional Q3FY26 results with revenue of ₹2,303.20 lakhs (up 13% YoY) and PAT surging 511% to ₹95.07 lakhs. Nine-month revenue grew 27% to ₹6,890.61 lakhs with PAT increasing 94% to ₹206.29 lakhs. The company completed UAE product registration and expects first export shipment in Q1 of next financial year. Strong performance driven by operational efficiency, market expansion, and higher-margin product categories.
10Jan 26
Deccan Health Care Limited Company Secretary Ronak Darji Resigns with Immediate Effect
Deccan Health Care Limited announced the immediate resignation of Company Secretary Ronak Darji effective December 01, 2025, citing financial hardship due to pending salary payments. The company appointed COO Mohita Gupta as designated compliance officer and expressed concerns about performance gaps and compliance issues during Darji's tenure. The resignation was accepted subject to proper handover procedures and continuing accountability for statutory compliance matters.
11Dec 25
Deccan Healthcare Appoints Independent Directors, Updates Leadership Team
Deccan Healthcare Limited has strengthened its board with two new Independent Director appointments - Samhitha Kandalkunta (5-year term) and Karishma D. Patel (1-year term) - effective December 11, 2025, based on Nomination Committee recommendations. The company also updated its leadership transition, with Mohita Gupta serving as Interim Compliance Officer following Ronak Darji's resignation as Company Secretary.
14Nov 25
Deccan Health Care Reports Robust Q2 Growth: Revenue Surges 29.7%, Profit Jumps 67.5%
Deccan Health Care reported robust Q2 FY2025-26 results with revenue increasing 29.7% YoY to ₹2,440.46 lakh and net profit surging 67.5% to ₹89.97 lakh. EBITDA margin improved to 7.0% from 3.4%. The company expanded its wellness portfolio with new product launches and introduced a Weight Wellness Program. Deccan Health Care is pursuing international growth with regulatory approvals filed in 6 markets and plans for product launches in UAE and GCC by March 2026.
01Oct 25
Deccan Health Care Reappoints Ruchi Khattar as Independent Director for Second Term
Deccan Health Care Limited has reappointed Ruchi Khattar as an Independent Director in the Non-Executive category for a second term of five years, from September 4, 2025, to September 3, 2030. The decision was approved by shareholders at the company's 29th Annual General Meeting. Khattar, with 25 years of experience in accounts, finance, and insurance compliance, is a graduate from Lady Sri Ram College, Delhi University. The company confirmed that Khattar is not related to any other directors and is not debarred from holding a directorship by any regulatory authority.
04Sept 25
Deccan Health Care Reappoints Ruchi Khattar as Independent Director, Approves Annual Report
Deccan Health Care's board has reappointed Ruchi Khattar as Independent Director for a second five-year term, approved the annual report for FY 2024-25, and scheduled the 29th AGM for September 30, 2025. The board also appointed M/s. M. R. Bhatia and Co. as Secretarial Auditors for five years and made decisions regarding the e-voting process and disclosure of material events.
14Aug 25
Deccan Health Care Limited Approves Q1 FY2026 Financial Results
Deccan Health Care Limited's Board of Directors approved the unaudited financial results for Q1 FY2026 ending June 30, 2025. The board meeting was held on August 14, 2025, via video conferencing. Both standalone and consolidated results were approved after review by the Audit Committee. Director Mohak Gupta is authorized to sign the results. The company will upload the results on its website and submit them to BSE Limited, complying with SEBI regulations.
Industry Peers
Dr. Lal Path Labs
Vijaya Diagnostic Centre
Metropolis Healthcare
Thyrocare Technologies
Nephrocare Health Services
Krsnaa Diagnostics
Suraksha Diagnostic
One Global Service Provider
Health X Platform
3B BlackBio DX
1,647.00
(-2.50%)
1,311.30
(-4.13%)
523.80
(-3.60%)
524.40
(+1.39%)
658.20
(+0.04%)
537.05
(-0.22%)
273.30
(+0.61%)
715.00
(-3.79%)
318.25
(-3.05%)
1,173.80
(+1.22%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
